Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Glucocorticoids have been the primary treatment of graft-versus-host disease (GVHD) over the past decade. Complete responses to steroid therapy are usually expected in almost one-third of aGVHD cases and partial response is anticipated in another one-third of patients. However, for those patients no...

Descripción completa

Detalles Bibliográficos
Autores principales: Nassar, Amr, Elgohary, Ghada, Elhassan, Tusneem, Nurgat, Zubeir, Mohamed, Said Y., Aljurf, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227326/
https://www.ncbi.nlm.nih.gov/pubmed/25405023
http://dx.doi.org/10.1155/2014/980301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227326/
https://www.ncbi.nlm.nih.gov/pubmed/25405023
http://dx.doi.org/10.1155/2014/980301

Ejemplares similares